ANALYSIS OF IMMUNITY IN OSTEOSARCOMA AS A BASIS FOR DEVELOPMENT FOLLOWING THERAPY
Background: Osteosarcoma is a malignant bone disease. Predictors which used to determine osteosarcoma from non-invasive (stage IIB) to invasive (stage III), through the ratio of macrophages-1 (M-1) which are pro-inflammatory (anti-cancer) with macrophages-2 (M-2) which have anti-inflammatory charact...
Saved in:
Main Authors: | Ferdiansyah Mahyudin, Mouli Edward, Muhammad Hardian Basuki, Kadek Seta Prawira |
---|---|
Format: | Article |
Language: | English |
Published: |
Universitas Airlangga
2019-12-01
|
Series: | Journal Orthopaedi and Traumatology Surabaya |
Subjects: | |
Online Access: | https://e-journal.unair.ac.id/JOINTS/article/view/16571 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
OSTEOSARCOMA HAS NOT BECOME ATTENTION TO SOCIETY PROFILE OF OSTEOSARCOMA PATIENTS AT DR. SOETOMO GENERAL HOSPITAL SURABAYA "A RETROSPECTIVE STUDY”
by: Ferdiansyah Mahyudin, et al.
Published: (2019-12-01) -
Inhibition of id-1 reduces osteosarcoma growth and metastasis through mediation of snail
by: Rongbing Shu, et al.
Published: (2025-01-01) -
Research Progress on Natural Products That Regulate miRNAs in the Treatment of Osteosarcoma
by: Lin Wang, et al.
Published: (2025-01-01) -
Immunotherapy of osteosarcoma based on immune microenvironment modulation
by: Heping Lian, et al.
Published: (2025-01-01) -
Using β-Elemene to reduce stemness and drug resistance in osteosarcoma: A focus on the AKT/FOXO1 signaling pathway and immune modulation
by: Shaochun Zhang, et al.
Published: (2025-02-01)